{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:27:48Z","timestamp":1774531668992,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,15]]},"DOI":"10.7759\/cureus.73724","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T09:46:33Z","timestamp":1731663993000},"source":"Crossref","is-referenced-by-count":2,"title":["Bleeding Phenotype of Glanzmann Thrombasthenia (GT) and Treatment Outcomes in Over One Hundred Patients: A Two-Center Experience in North Pakistan"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Usman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryum","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nighat","family":"Shahbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna","family":"Zaffar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hira","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raheel","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Ghafoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehreen Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahira","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1353393","article-title":"Glanzmann thrombasthenia: state of the art and future directions","volume":"39","author":"Nurden AT","year":"2013","unstructured":"Nurden AT, Pillois X, Wilcox DA. Glanzmann thrombasthenia: state of the art and future directions. Semin Thromb Hemost. 2013, 39:642-55. 10.1055\/s-0033-1353393","journal-title":"Semin Thromb Hemost"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100802123365","article-title":"AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3","volume":"19","author":"Afrasiabi A","year":"2008","unstructured":"Afrasiabi A, Gelain F, Artoni A, Mannucci PM. AlphaIIbG236E causes Glanzmann thrombasthenia by impairing association with beta3. Platelets. 2008, 19:322-7. 10.1080\/09537100802123365","journal-title":"Platelets"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000870","article-title":"Clinico-hematological and thromboelastographic profiles in glanzmann's thrombasthenia","volume":"31","author":"Ahammad J","year":"2020","unstructured":"Ahammad J, Kamath A, Shastry S, Chitlur M, Kurien A. Clinico-hematological and thromboelastographic profiles in glanzmann's thrombasthenia. Blood Coagul Fibrinolysis. 2020, 31:29-34. 10.1097\/MBC.0000000000000870","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI108805","article-title":"Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins","volume":"60","author":"Phillips DR","year":"1977","unstructured":"Phillips DR, Agin PP. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest. 1977, 60:535-45. 10.1172\/JCI108805","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2002.03812.x","article-title":"Fanconi and Glanzmann: the men and their works","volume":"119","author":"Stevens RF","year":"2002","unstructured":"Stevens RF, Meyer S. Fanconi and Glanzmann: the men and their works. Br J Haematol. 2002, 119:901-4. 10.1046\/j.1365-2141.2002.03812.x","journal-title":"Br J Haematol"},{"key":"ref6","article-title":"Diagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum","volume":"18","author":"Ali N","year":"2008","unstructured":"Ali N, Moiz B, Shaikh U, Adil S, Rizvi B, Rahman Y. Diagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum. J Coll Physicians Surg Pak. 2008, 18:91-4.","journal-title":"J Coll Physicians Surg Pak"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/09537104.2017.1386297","article-title":"Diagnosis of platelet function disorders: a standardized, rational, and modular flow cytometric approach","volume":"29","author":"Andres O","year":"2018","unstructured":"Andres O, Henning K, Strau\u00df G, Pflug A, Manukjan G, Schulze H. Diagnosis of platelet function disorders: a standardized, rational, and modular flow cytometric approach. Platelets. 2018, 29:347-56. 10.1080\/09537104.2017.1386297","journal-title":"Platelets"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12320","article-title":"Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry","volume":"37","author":"Albanyan A","year":"2015","unstructured":"Albanyan A, Al-Musa A, AlNounou R, et al.. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry. Int J Lab Hematol. 2015, 37:503-8. 10.1111\/ijlh.12320","journal-title":"Int J Lab Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14623","article-title":"Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions","volume":"181","author":"Al-Battat S","year":"2018","unstructured":"Al-Battat S, Rand ML, Bouskill V, et al.. Glanzmann thrombasthenia platelets compete with transfused platelets, reducing the haemostatic impact of platelet transfusions. Br J Haematol. 2018, 181:410-3. 10.1111\/bjh.14623","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0268-960x(02)00030-9","article-title":"Molecular basis of Glanzmann's thrombasthenia and current strategies in treatment","volume":"16","author":"Bellucci S","year":"2002","unstructured":"Bellucci S, Caen J. Molecular basis of Glanzmann's thrombasthenia and current strategies in treatment. Blood Rev. 2002, 16:193-202. 10.1016\/s0268-960x(02)00030-9","journal-title":"Blood Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020213","article-title":"Glanzmann thrombasthenia in Pakistani patients: identification of 7 novel pathogenic variants in the fibrinogen receptor \u03b1IIb\u03b23","volume":"12","author":"Siddiqi MY","year":"2023","unstructured":"Siddiqi MY, Boeckelmann D, Naz A, Imran A, Ahmed S, Najmuddin A, Zieger B. Glanzmann thrombasthenia in Pakistani patients: identification of 7 novel pathogenic variants in the fibrinogen receptor \u03b1IIb\u03b23. Cells. 2023, 12:10.3390\/cells12020213","journal-title":"Cells"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.gpeds.2022.100026","article-title":"Glanzmann thrombasthenia\u2014a not so rare platelet function disorder in Pakistan","volume":"2","author":"Mahmood R","year":"2022","unstructured":"Mahmood R, Malik HS, Khan M, Ali S, Mahmood A, Khan SA. Glanzmann thrombasthenia\u2014a not so rare platelet function disorder in Pakistan. Global Pediatrics. 2022, 2:100026. 10.1016\/j.gpeds.2022.100026","journal-title":"Global Pediatrics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman S","year":"2005","unstructured":"Schulman S, Kearon C. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost. 2005, 3:692-4. 10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/09537100220122466","article-title":"A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia","volume":"13","author":"Nurden AT","year":"2002","unstructured":"Nurden AT, Ruan J, Pasquet JM, Gauthier B, Combri\u00e9 R, Kunicki T, Nurden P. A novel 196Leu to Pro substitution in the beta3 subunit of the alphaIIbbeta3 integrin in a patient with a variant form of Glanzmann thrombasthenia. Platelets. 2002, 13:101-11. 10.1080\/09537100220122466","journal-title":"Platelets"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S71319","article-title":"Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options","volume":"6","author":"Solh T","year":"2015","unstructured":"Solh T, Botsford A, Solh M. Glanzmann's thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options. J Blood Med. 2015, 6:219-27. 10.2147\/JBM.S71319","journal-title":"J Blood Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S271744","article-title":"Glanzmann thrombasthenia: perspectives from clinical practice on accurate diagnosis and optimal treatment strategies","volume":"12","author":"Mathews N","year":"2021","unstructured":"Mathews N, Rivard GE, Bonnefoy A. Glanzmann thrombasthenia: perspectives from clinical practice on accurate diagnosis and optimal treatment strategies. J Blood Med. 2021, 12:449-63. 10.2147\/JBM.S271744","journal-title":"J Blood Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0950-3536(89)80036-8","article-title":"Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George JN","year":"1990","unstructured":"George JN, Caen JP, Nurden AT. Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease. Blood. 1990, 75:1383-95. 10.1016\/s0950-3536(89)80036-8","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2257.2005.00725.x","article-title":"Glanzmann thrombasthenia and Bernard-Soulier syndrome in south Iran","volume":"27","author":"Afrasiabi A","year":"2005","unstructured":"Afrasiabi A, Artoni A, Karimi M, Peyvandi F, Ashouri E, Mannucci PM. Glanzmann thrombasthenia and Bernard-Soulier syndrome in south Iran. Clin Lab Haematol. 2005, 27:324-7. 10.1111\/j.1365-2257.2005.00725.x","journal-title":"Clin Lab Haematol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1721500","article-title":"Prevalence of coagulation factors deficiency among young adults in Saudi Arabia: a national survey","volume":"4","author":"AlSaleh KA","year":"2020","unstructured":"AlSaleh KA, Al-Numair N, AlSuliman A, et al.. Prevalence of coagulation factors deficiency among young adults in Saudi Arabia: a national survey. TH Open. 2020, 4:e457-62. 10.1055\/s-0040-1721500","journal-title":"TH Open"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12017","article-title":"Pattern of bleeding and response to therapy in Glanzmann thrombasthenia","volume":"18","author":"Borhany M","year":"2012","unstructured":"Borhany M, Fatima H, Naz A, Patel H, Shamsi T. Pattern of bleeding and response to therapy in Glanzmann thrombasthenia. Haemophilia. 2012, 18:e423-5. 10.1111\/hae.12017","journal-title":"Haemophilia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1080\/09537100903006246","article-title":"Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia","volume":"20","author":"Awidi A","year":"2009","unstructured":"Awidi A, Maqablah A, Dweik M, Bsoul N, Abu-Khader A. Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia. Platelets. 2009, 20:297-301. 10.1080\/09537100903006246","journal-title":"Platelets"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.214239","article-title":"Glanzmann thrombasthenia: genetic basis and clinical correlates","volume":"105","author":"Botero JP","year":"2020","unstructured":"Botero JP, Lee K, Branchford BR, et al.. Glanzmann thrombasthenia: genetic basis and clinical correlates. Haematologica. 2020, 105:888-94. 10.3324\/haematol.2018.214239","journal-title":"Haematologica"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-020-0887-y","article-title":"Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review","volume":"20","author":"Magnay JL","year":"2020","unstructured":"Magnay JL, O'Brien S, Gerlinger C, Seitz C. Pictorial methods to assess heavy menstrual bleeding in research and clinical practice: a systematic literature review. BMC Womens Health. 2020, 20:24. 10.1186\/s12905-020-0887-y","journal-title":"BMC Womens Health"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.121384","article-title":"The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention","volume":"100","author":"Poon MC","year":"2015","unstructured":"Poon MC, d'Oiron R, Zotz RB, Bindslev N, Di Minno MN, Di Minno G. The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention. Haematologica. 2015, 100:1038-44. 10.3324\/haematol.2014.121384","journal-title":"Haematologica"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25910","article-title":"Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects","volume":"95","author":"Blaauwgeers MW","year":"2020","unstructured":"Blaauwgeers MW, Kruip MJ, Beckers EA, et al.. Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects. Am J Hematol. 2020, 95:1142-7. 10.1002\/ajh.25910","journal-title":"Am J Hematol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14683","article-title":"Validation of the ISTH\/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC","volume":"18","author":"Gresele P","year":"2020","unstructured":"Gresele P, Orsini S, Noris P, et al.. Validation of the ISTH\/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC. J Thromb Haemost. 2020, 18:732-9. 10.1111\/jth.14683","journal-title":"J Thromb Haemost"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S418937","article-title":"Glanzmann thrombasthenia associated with siderotic synovitis and arthropathy: a case report","volume":"14","author":"Alawad MJ","year":"2023","unstructured":"Alawad MJ, Abu-Tineh M, Alshurafa A, Al-Taie A, Yousaf A, Yassin MA. Glanzmann thrombasthenia associated with siderotic synovitis and arthropathy: a case report. J Blood Med. 2023, 14:563-7. 10.2147\/JBM.S418937","journal-title":"J Blood Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.25259\/SNI_680_2023","article-title":"Two case reports of Glanzmann thrombasthenia with intracranial hemorrhage and a review of the literature","volume":"14","author":"Almesedin GS","year":"2023","unstructured":"Almesedin GS, Alshmaily HO, Alshammari KA, Albalawi RS. Two case reports of Glanzmann thrombasthenia with intracranial hemorrhage and a review of the literature. Surg Neurol Int. 2023, 14:448. 10.25259\/SNI_680_2023","journal-title":"Surg Neurol Int"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000001026","article-title":"Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia","volume":"32","author":"Andi\u00e7 N","year":"2021","unstructured":"Andi\u00e7 N, O\u011fuz N, G\u00fcnd\u00fcz E, Kiraz Bulduk T, \u00dcsk\u00fcdar Teke H. Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia. Blood Coagul Fibrinolysis. 2021, 32:349-51. 10.1097\/MBC.0000000000001026","journal-title":"Blood Coagul Fibrinolysis"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21122","article-title":"Management of persistent gastric bleeding in a patient with Glanzmann's thrombasthenia","volume":"83","author":"Bakdash S","year":"2008","unstructured":"Bakdash S, Lyons JM, Bastacky SI, et al.. Management of persistent gastric bleeding in a patient with Glanzmann's thrombasthenia. Am J Hematol. 2008, 83:411-5. 10.1002\/ajh.21122","journal-title":"Am J Hematol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610364518","article-title":"Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia","volume":"17","author":"Balci YI","year":"2011","unstructured":"Balci YI, Karabulut A, Kabukcu S, Sari I, Keskin A. Intensive menstrual bleeding successfully treated with recombinant factor VIIa in Glanzmann thrombasthenia. Clin Appl Thromb Hemost. 2011, 17:320-2. 10.1177\/1076029610364518","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1007\/s12098-011-0364-6","article-title":"Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience","volume":"78","author":"Bhat S","year":"2011","unstructured":"Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A. Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. Indian J Pediatr. 2011, 78:961-8. 10.1007\/s12098-011-0364-6","journal-title":"Indian J Pediatr"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12156","article-title":"Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders","volume":"19","author":"Birschmann I","year":"2013","unstructured":"Birschmann I, Klamroth R, Eichler H, Schenk J, Kirchmaier CM, Halimeh S. Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders. Haemophilia. 2013, 19:679-85. 10.1111\/hae.12156","journal-title":"Haemophilia"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2022.281973","article-title":"The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status","volume":"108","author":"Poon MC","year":"2023","unstructured":"Poon MC, D'Oiron R, Baby S, Zotz RB, Di Minno G. The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status. Haematologica. 2023, 108:2855-8. 10.3324\/haematol.2022.281973","journal-title":"Haematologica"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0000000000000608","article-title":"Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions","volume":"27","author":"Lee RH","year":"2020","unstructured":"Lee RH, Kasthuri RS, Bergmeier W. Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions. Curr Opin Hematol. 2020, 27:378-85. 10.1097\/MOH.0000000000000608","journal-title":"Curr Opin Hematol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12652","article-title":"The lived experience of women with a bleeding disorder: a\u00a0systematic review","volume":"6","author":"Sanigorska A","year":"2022","unstructured":"Sanigorska A, Chaplin S, Holland M, Khair K, Pollard D. The lived experience of women with a bleeding disorder: a\u00a0systematic review. Res Pract Thromb Haemost. 2022, 6:e12652. 10.1002\/rth2.12652","journal-title":"Res Pract Thromb Haemost"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2147\/PROM.S211339","article-title":"Hemophilia and sexual health: results from the HERO and B-HERO-S studies","volume":"10","author":"Blamey G","year":"2019","unstructured":"Blamey G, Buranahirun C, Buzzi A, et al.. Hemophilia and sexual health: results from the HERO and B-HERO-S studies. Patient Relat Outcome Meas. 2019, 10:243-55. 10.2147\/PROM.S211339","journal-title":"Patient Relat Outcome Meas"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000286","article-title":"Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report","volume":"3","author":"Rodeghiero F","year":"2019","unstructured":"Rodeghiero F, Pabinger I, Ragni M, et al.. Fundamentals for a systematic approach to mild and moderate inherited bleeding disorders: an EHA consensus report. Hemasphere. 2019, 3:e286. 10.1097\/HS9.0000000000000286","journal-title":"Hemasphere"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/299502-bleeding-phenotype-of-glanzmann-thrombasthenia-gt-and-treatment-outcomes-in-over-one-hundred-patients-a-two-center-experience-in-north-pakistan","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T09:46:36Z","timestamp":1731663996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/299502-bleeding-phenotype-of-glanzmann-thrombasthenia-gt-and-treatment-outcomes-in-over-one-hundred-patients-a-two-center-experience-in-north-pakistan"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.73724","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,15]]}}}